News

Findings from the ELSA study show that population-based screening using a simple dried blood spot test is highly feasible and well accepted by families.

FDA grants priority review to marstacimab for hemophilia A or B in children 6 years and older and patients with inhibitors.

A recent study found that nearly half of parents of children with high weight reported concerns about disordered eating.

FDA and partners are investigating a multistate infant botulism outbreak linked to powdered formula and assessing risks of Clostridium botulinum.

Giulia M. Muraca, PhD, MPH, and Maya Rajasingham, BSc, discuss new data comparing neurodevelopmental outcomes in children born via second-stage cesarean and assisted vaginal delivery.

A study shows how COVID-19 reshaped the circulation, seasonality, and coinfection patterns of respiratory viruses in children.

Experts urge culturally responsive nutrition counseling, noting the new Dietary Guidelines lack guidance on diverse food traditions and eating patterns.

Experts discuss access, affordability, and equity challenges in applying the new Dietary Guidelines, urging clinicians to reduce guilt and personalize care.

Experts debate stricter added sugar recommendations in the new Dietary Guidelines, stressing practicality, age-specific needs, and personalized counseling.

Experts highlight gaps in the new Dietary Guidelines, including fiber, whole grains, plant-based milks, and simplified alcohol guidance.

Experts unpack saturated fat recommendations in the 2025–2030 Dietary Guidelines, highlighting visual misalignment and the need for personalized counseling.

Experts clarify protein recommendations in the 2025–2030 Dietary Guidelines, emphasizing quality, preparation, and clinician-led patient education.

Experts discuss whole-foods emphasis, microbiome insights, and consumer-focused changes in the 2025–2030 US Dietary Guidelines for clinicians.

Take a quick look at everything you may have missed this past month, including the top FDA approvals and latest clinical updates.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from January 2026.

Deep transfer learning models may enable more accurate, globally applicable prediction of spoken language outcomes in deaf children receiving cochlear implants.

A study found that dried blood spot screening can identify presymptomatic type 1 diabetes in children, reducing the risk of diabetic ketoacidosis.

A study found that an FDA-cleared device was safe for pediatric patients with ADHD but did not significantly improve symptoms vs sham treatment.

Family systems assessments help clinicians understand how parenting, co-parenting, and family relationships shape children’s mental health.

AbbVie submitted FDA and EMA applications for upadacitinib (RINVOQ) in adults and adolescents with non-segmental vitiligo, supported by phase 3 Viti-Up data.

About one-fourth of young children who experience a concussion continue to show symptoms months after injury.

Phase 2 INTEGUMENT-INFANT study results show roflumilast cream 0.05% was well tolerated and improved disease severity in infants with atopic dermatitis.

Experts are urging caution with pediatric melatonin use, citing rising consumption, inconsistent dosing, and limited long-term safety data.

The FDA has issued a CRL for Anaphylm sublingual epinephrine, citing human factors and PK study needs; resubmission is anticipated in Q3 2026.

A comprehensive review of high-quality studies found no evidence that prenatal paracetamol use increases the risk of autism, ADHD, or intellectual disability.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Increasing numbers, complexity, and severity of maternal chronic conditions are associated with a dose-response rise in severe neonatal morbidity and mortality.

Youth suicide data highlight firearm safety counseling and universal screening as key prevention tools, especially for youth without prior mental health contact.